Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
- Cell and Gene Therapy at a Turning Point January 30, 2026
- Sepsis Gap & Home Testing Growth: Interview with Kalorama Information’s Daniel Granderson January 9, 2026
- What Is the Size of the IVD Market in 2025? September 8, 2025
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Pets are Key to $3.5 Billion Veterinary Diagnostic Testing Market
“Companion animals (including dogs, cats, and horses) account for 70% of overall market, finds new report by Kalorama Information” – Kalorama Information In the global veterinary diagnostic testing market, the companion animal segment (pets and domestic animals including horses) comprises almost 70% of the $3,540 million ($3.5 billion) overall market, with the food animal segment […]
Molecular Point of Care Market Reaches 3.5 Billion
The molecular point of care market reached 3,555 million in 2021, according to Kalorama Information’s latest report. The Market and Potential for Molecular Point-of-Care. COVID-19 sales were the main driver. That is 10x growth in revenues from 2019. The COVID-19 pandemic and consistent arrival of variants are the determining factor, and the continued presence of […]
14 Recent Developments in Cell and Gene Therapy as of March 22, 2022
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. EdiGene, a gene-editing company based in Beijing, China, has entered a non-exclusive, worldwide license agreement with Boston Children’s Hospital (BCH) for intellectual property rights covering the upregulation of fetal hemoglobin […]
VIDEO: 5 Key Trends in Cell and Gene Therapy
Learn about these 5 key trends based on research featured in Cell Therapy and Gene Therapy Markets, 2021-2031 (published Feb. 2022), a recent report by Kalorama Information Cell and gene therapy products are transforming the treatment of many acquired diseases such as cancer, diabetes, Parkinson’s disease and genetic diseases to correct defective genetic material. Additionally, […]
Veterinary Diagnostics: COVID-19 Pandemic Can’t Slow Momentum of $3.5 Billion Market
“The veterinary diagnostics market represents a fast-growing opportunity to IVD companies and others able to capitalize on the unfailing need to ensure agricultural productivity and the growth in consumer spending on companion animals.” – Kalorama Information The veterinary diagnostics market has experienced steady growth through the ravages of the pandemic and is forecast […]
11 Recent Developments in Cell and Gene Therapy as of March 2022
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. The US Patent and Trademark Office has ruled against a patent challenge by the University of California, Berkeley (UC Berkeley) over patents awarded to the Broad Institute of MIT and […]
Tenfold Growth for $5.2 Billion Cell and Gene Therapy Market from 2021-2031
“Oncology, cardiovascular-blood and genetic conditions will be key contributors to the cell and gene therapy market’s strong performance through 2031.” – Kalorama Information It is an exciting and interesting time for companies involved in cell and gene therapy as the industry is forecast to grow tenfold between 2021 to 2031, according to leading medical […]
Funding for Cell and Gene Therapies Exceeded 70 Billion Last Year: Kalorama Report
Total funding from all sources for cell and gene therapy companies totaled $70.8 billion last year, according to a compilation of deals performed by Kalorama Information as part of its recent report. The growth in money being injected into cell and gene therapy companies continues to grow in 2022, according to the firm’s report: Cell […]
Cardiovascular Disease Pumps Sales of Cardiac Markers to $2,517 Million
“With the incidence of cardiovascular disease escalating, cardiac markers are in huge demand and a constant subject of research for improvement.” – Kalorama Information Despite improvements in treatment and increased public awareness about prevention, cardiovascular disease (CVD) is still the leading cause of death worldwide. CVD causes half of all deaths in several developed countries […]
10 Recent Developments in Cell and Gene Therapy
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Intellia Therapeutics, based in Cambridge, MA, has acquired Berkeley, CA-based Rewrite Therapeutics, a private biotech company specializing in developing novel genome editing technologies. Rewrite’s Rewriter platform utilizes CRISPR-guided DNA polymerases […]